KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Payables (2016 - 2025)

Historic Payables for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Boston Scientific's Payables rose 1916.67% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 1916.67%. This contributed to the annual value of $1.1 billion for FY2025, which is 1916.67% up from last year.
  • Latest data reveals that Boston Scientific reported Payables of $1.1 billion as of Q4 2025, which was up 1916.67% from $1.0 billion recorded in Q3 2025.
  • Boston Scientific's Payables' 5-year high stood at $1.1 billion during Q4 2025, with a 5-year trough of $615.0 million in Q1 2021.
  • For the 5-year period, Boston Scientific's Payables averaged around $865.4 million, with its median value being $902.5 million (2023).
  • Per our database at Business Quant, Boston Scientific's Payables skyrocketed by 6887.25% in 2021 and then tumbled by 236.81% in 2024.
  • Over the past 5 years, Boston Scientific's Payables (Quarter) stood at $794.0 million in 2021, then increased by 8.56% to $862.0 million in 2022, then grew by 9.28% to $942.0 million in 2023, then increased by 1.91% to $960.0 million in 2024, then grew by 19.17% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.0 billion for Q3 2025, and $962.0 million during Q2 2025.